ITC starts clinical trials of nasal spray for COVID-19 prevention

ITC starts clinical trials of nasal spray for COVID-19 prevention Developed by scientists at ITC Life Sciences and Technology Centre (LSTC), Bengaluru, the company plans to market the nasal spray under the Savlon brand once it gets all the requisite regulatory approvals, according to sources.

No comments:

Post a Comment